Day: March 2, 2021

Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the ‘Ketamine in the Reduction of Alcoholic Relapse’ (KARE) Intervention Validated in a Phase II Clinical Trial

Awakn intends to run a Phase III trial for 'Ketamine-Assisted Psychotherapy for Alcohol Use Disorder'London, United Kingdom--(Newsfile Corp. - March...

Strong Start to 2021: Glocal Healthcare Team Signs Contracts in Namibia and Uzbekistan and is Recognized by Her Majesty, Queen Mathilde of Belgium as Leading, International Healthcare Innovator

KOLKATA, India & DELRAY BEACH, Fla.--(BUSINESS WIRE)--Glocal Healthcare Systems (“Glocal” or the “Company”), a global industry-leading provider of digitally enabled...

error: Content is protected !!